Kucuk Can, Ozkan Metin, Akgun Hulya, Muhtaroglu Sebahattin, Sozuer Erdogan
Department of General Surgery, Erciyes University School of Medicine, Kayseri, Turkey.
J Surg Res. 2005 Sep;128(1):15-20. doi: 10.1016/j.jss.2005.04.037.
After surgical resection for colorectal carcinoma there is a high recurrence rate and, therefore, adjuvant chemotherapy may be useful in some patients. 5-Fluorouracil (5-FU) is the most commonly used chemotherapeutic agent in the management of patients with colorectal cancer. However, gastrointestinal injury induced by chemotherapeutic agents may result in bacterial translocation from the gut into the systemic circulation. Granulocyte macrophage-colony stimulating factor (GM-CSF) may be used to prevent this side effect by means of macrophage activity stimulation.
A total of 45 rats were divided into three groups. Control group received intraperitoneal saline solution, 5-FU and GM-CSF groups received 50 mg/kg/day 5-FU intravenous infusion and GM-CSF group also received 200 ng/day GM-CSF subcutaneously for 6 days. Intestinal tissue was also sampled for pathological examination at day 7. Plasma levels of tumor necrosis factor-alpha and interleukin-6 were determined, bacterial translocation was quantified by lymph node, liver and spleen culture, and plasma endotoxin content was measured.
White blood cell counts of the 5-FU rats were significantly lower than in the control and GM-CSF groups (P < 0.01). The plasma endotoxin, tumor necrosis factor-alpha and interleukin-6 levels in the 5-FU and GM-CSF groups were significantly increased at day 7 compared with the control groups (P < 0.01), but these levels were significantly lower in the GM-CSF group compared to the 5-FU group (P < 0.01). 5-FU intervention caused significant increase in the frequencies of bacterial translocation at liver, spleen, mesenteric lymph node, and portal blood. Compared with 5-FU group, GM-CSF decreased the bacterial translocation (P < 0.01).
This study observed that the administration of 5-FU resulted in bacterial translocation. Activation of inflammatory response with GM-CSF is highly effective in prevention of bacterial translocation in 5-FU interventions.
结直肠癌手术切除后复发率较高,因此辅助化疗对部分患者可能有用。5-氟尿嘧啶(5-FU)是结直肠癌患者治疗中最常用的化疗药物。然而,化疗药物引起的胃肠道损伤可能导致细菌从肠道转移至体循环。粒细胞巨噬细胞集落刺激因子(GM-CSF)可通过刺激巨噬细胞活性来预防这种副作用。
总共45只大鼠被分为三组。对照组接受腹腔内生理盐水,5-FU组和GM-CSF组接受50mg/kg/天的5-FU静脉输注,GM-CSF组还接受200ng/天的GM-CSF皮下注射,持续6天。在第7天也采集肠道组织进行病理检查。测定血浆肿瘤坏死因子-α和白细胞介素-6水平,通过淋巴结、肝脏和脾脏培养对细菌转移进行定量,并测量血浆内毒素含量。
5-FU组大鼠的白细胞计数显著低于对照组和GM-CSF组(P<0.01)。与对照组相比,5-FU组和GM-CSF组在第7天的血浆内毒素、肿瘤坏死因子-α和白细胞介素-6水平显著升高(P<0.01),但GM-CSF组的这些水平显著低于5-FU组(P<0.01)。5-FU干预导致肝脏、脾脏、肠系膜淋巴结和门静脉血中细菌转移的频率显著增加。与5-FU组相比,GM-CSF减少了细菌转移(P<0.01)。
本研究观察到5-FU的给药导致细菌转移。GM-CSF激活炎症反应在预防5-FU干预中的细菌转移方面非常有效。